FindTrial
Sign In

Clinical Study on Treating Ankylosing Spondylitis with Chinese Herbal Decoction Zhitongzhu Decoction

Clinical Study on Treating Ankylosing Spondylitis with Chinese Herbal Decoction Zhitongzhu Decoction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17013574
Enrollment
Unknown
Registered
2017-11-28
Start date
2018-06-01
Completion date
Unknown
Last updated
2017-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankylosing spondylitis

Interventions

control group :Leflunomide
Intervention group :Chinese herbalshentongzhuyudecoction

Sponsors

The First Affiliated Hospital of Heilongjiang Chinese Medicine Colledge
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
16 Years to 25 Years

Inclusion criteria

Inclusion criteria: Forty patients diagnosed according to the International Classification of Ankylosing Spondylitis were all outpatients and inpatients with rheumatism and immunology in our hospital. Choices: (1) male patients, aged 16 to 25 years old; (2) did not use corticosteroids, HCQs and other drugs within 1 month before enrollment.

Exclusion criteria

Exclusion criteria: (1) allergic constitution; (2) accompanied by viral hepatitis, alcoholic liver disease, fatty liver and drug-induced liver disease.

Design outcomes

Primary

MeasureTime frame
Rheumatoid factor;HL-B27;—

Countries

China

Contacts

Public ContactYing Tong

The First Affiliated Hospital of Heilongjiang Chinese Medicine Colledge

tymm0451@126.com+86 186867800398

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026